Navigation Links
Current Regulatory Expectations Affecting the Validation of Reusable Medical Devices is Subject of Dec. 4th Seminar in Boston
Date:11/12/2013

AGAWAM, Mass., Nov. 12, 2013 /PRNewswire/ -- A half-day seminar focusing on current regulatory expectations in the validation of reusable medical devices is the subject of a seminar set for Dec. 4th in Waltham, Mass., near Boston.

The validation of reusable medical devices is at the forefront of the FDA's efforts to ensure patient safety. Requirements for the cleaning, disinfection, and sterilization of reusable devices are constantly changing. The situation challenges manufacturers both in terms of deciding which testing methods to employ as well as the planning of end points.

The seminar will provide attendees with the knowledge they need to know about current regulatory expectations so they may better prepare their submissions for FDA acceptance — and avoid the time-consuming and costly requirements of additional testing.

Seminar topics will include:

  • Discussion of the FDA's draft guidance for industry and FDA staff, "Processing/ Preprocessing Medical Devices in Healthcare Settings"
  • Methods used for the cleaning and validation of reusable devices
  • Methods for the disinfection of reusable devices
  • Methods for the sterilization of reusable devices
  • Testing requirements
  • Detailed discussion of endpoints for cleaning validation

The seminar will be presented by Microtest Laboratories, a leader in testing services and contract manufacturing for the medical device, pharmaceutical, and biotechnology industries, on Wednesday, Dec. 4, 2013, from 9 a.m. to 1 p.m. at the Conference Center at Waltham Woods in Waltham, Mass., just outside Boston. Registration is at 9 a.m. A continental breakfast, break refreshments, and a luncheon are included.

To register, visit http://goo.gl/DvaECn or contact Julie Adamski 1-800-631-1680, ext. 192, or jadamski@microtestlabs.com. Advance registration is $149.

About Microtest Laboratories    
Microtest Laboratories is a leader in testing services and contract manufacturing for the medical device, pharmaceutical, and biotechnology industries. Based in Agawam, Massachusetts, USA, the company provides expertise and flexible processes that enhance product safety and security, accelerate time to market, and minimize supply chain disruption. For more information, visit http://www.microtestlabs.com or call 1-413-786-1680 or toll-free 1-800-631-1680. Follow Microtest Laboratories on Facebook at http://facebook.com/MicrotestLaboratories, on LinkedIn at http://goo.gl/H8ZLnM or on Twitter @MicrotestLabs.

Available Topic Expert(s): For information on the listed expert(s), click appropriate link.
Steve Richter, Ph.D.    
https://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=42622


'/>"/>
SOURCE Microtest Laboratories
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Janssen Research & Development Submits XARELTO® (rivaroxaban) to U.S. FDA for the Treatment and Prevention of Recurrent Venous Thromboembolism
2. Thomson Reuters Annual Pharmaceutical Factbook Reveals Key Insights into Current Trends
3. The New Generation of Antibody Therapeutics: Current Status and Future Prospects - Overview
4. Pharma IQs Laboratory Informatics Report: Current Trends & Predictions for 2015
5. ECRI Institute Helps Hospitals Design Spaces for Current and Future Technologies
6. Branded Generics in South East Asia: Current and Future Opportunities
7. Valeant Pharmaceuticals Announces Launch of Concurrent Private Offerings of Senior Notes
8. Valeant Pharmaceuticals International, Inc. Announces Pricing Of Concurrent Private Offerings Of Senior Notes
9. Chimerix Presents Data Highlighting Burden Of Care Associated With Current Antiviral Therapies In Stem Cell Transplantation
10. Novel Apolipoprotein A-I Therapy, CSL112, May Represent New Option for Reducing Recurrent Heart Attack Risk, Early CSL Studies Show
11. Valeritas Announces The Publication Of A Retrospective Analysis Of Patient-Reported Data On The V-Go In The Current Issue Of Endocrine Practice
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/26/2020)... ... August 26, 2020 , ... ... into definitive agreement to acquire ProCE, a nationally recognized provider of continuing ... , CEA represents a growing alliance of CME/CE and service organizations ...
(Date:8/26/2020)... (PRWEB) , ... August 26, 2020 , ... Hero ... a target goal of 115 million 3 ply surgical disposable face masks and N95 ... is in direct response to the challenge that most Americans are facing in trying ...
(Date:8/26/2020)... ... ... anywhere in the body typically makes us stop what we’re doing – and that’s especially ... problem in your spine, or something else? , The short answer is: It depends, says ... so prevalent that it’s the second most common reason Americans see a doctor, according to ...
Breaking Medicine Technology:
(Date:8/31/2020)... ... ... Want to get moving, break up your routine, and make a difference right ... its fourth annual STEPtember campaign in the United States to raise funds and awareness ... at this moment — encouraging people to move in the ways that work for ...
(Date:8/31/2020)... ... August 31, 2020 , ... Colorado State ... high-quality, career-relevant, and affordable online education – is proud to announce its new ... the first of its kind in the nation, the 60-credit hour program is ...
(Date:8/31/2020)... ... 2020 , ... The pandemic and topsy-turvy economic outlook continues to put financial strain on many ... to trim the fat from our monthly expenses and put more into savings, if possible. ... you have a financial safety net in place in case something were to happen to ...
(Date:8/31/2020)... ... ... In an effort to give back to the community in which it serves, ... with a special new rate code to benefit children and families at Ronald ... will be applied to any room type, any time, now through the end of ...
(Date:8/31/2020)... ... August 31, 2020 , ... Bonde Innovations, LLC, a venture-backed ... heart failure, today announced that the company has been awarded a Phase 1 ... National Heart, Lung, and Blood Institute of the National Institutes of Health (NIH). ...
Breaking Medicine News(10 mins):